Real-time detection of pathogens using customized nanoparticle biosensors with Fred Byerlein, MBA & Houng-Yau Mei, Ph.D., MBA
Mr. Beyerlein has over 30 years of extensive experience in early stage enterprise development product and market strategy, financial systems and overall business strategy. Mr. Beyerlein currently serves as the CEO of nanoRETE, Inc.; a biosensor development company focused on pathogen and toxin detection within the food safety and supply markets. Mr. Beyerlein received his MBA in Economics and Finance from Fordham University.
Dr. Mei received his Ph.D. degree from Columbia University followed by a NIH-postdoctoral fellowship at the University of California and an Executive MBA from Michigan State University. He has worked at Pfizer and Parke-Davis Pharmaceuticals, Rubicon Genomics, and Neural Intervention Technologies. Dr. Mei has over 60 patent applications, publications & abstracts..
Agenda: 1. Introduction. 2. What are human pathogens, such as anthrax, E. Coli, salmonella, tuberculosis? 3. What are the traditional methods of detection? 4. Is there a need for in-field, rapid testing results? 5. What is bio-barcode technology? a. Nano particle-presence/absence metal-ion 6. What advantages does multiplex testing offer? 7. What is square wave anodic stripping voltammetry (SWASV)? 8. Why is the reporting of test results within an hour advantageous? 9. What is the price of these new technologies? 10. Conclusion.
Contact: Fred Beyerlein, BS/MBA Chief Executive Officer nanoRETE, Inc. 3815 Technology Blvd. #1050 Lansing, MI 48910 517.336.4680 email@example.com http://www.nanorete.com